In 2023, government budget appropriations or outlays for R&D in health in Italy were below 13.6 billion USD (PPP, constant). The forecast for 2024 is 13.6 billion USD, increasing steadily to 14.81 billion USD by 2028. This represents a compound annual growth rate (CAGR) of approximately 2.14% over the five-year period. Year-on-year growth is projected to be around 2.3% from 2024 to 2028, indicating consistent investment growth in health R&D.
Future trends to watch for:
- Impact of global economic conditions on budget allocations.
- Italy's prioritization of health R&D in response to emerging health challenges.
- Evolving technologies and their influence on R&D funding needs.
